Activist 13D/13G Filings - Medicxi Growth I LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-01-26
4:00 pm
Purchase
13GPHATHOM PHARMACEUTICALS INC CO
PHAT
Medicxi Growth I LP7,464,572
13.000%
4,980,298increase
(+200.47%)
View
2023-01-31
4:00 pm
Purchase
13GCentessa Pharmaceuticals plc
CNTA
Medicxi Growth I LP19,963,157
21.100%
1,839,265increase
(+10.15%)
View
2023-01-31
4:00 pm
Purchase
13GPHATHOM PHARMACEUTICALS INC CO
PHAT
Medicxi Growth I LP2,484,274
6.000%
416,413increase
(+20.14%)
View
2022-02-08
08:27 am
Purchase
13GCentessa Pharmaceuticals plc
CNTA
Medicxi Growth I LP18,123,892
20.160%
18,123,892increase
(New Position)
View
2021-11-10
3:21 pm
Purchase
13DAura Biosciences Inc.
AURA
Medicxi Growth I LP3,039,892
10.700%
3,039,892increase
(New Position)
View
2021-02-11
10:27 am
Unchanged
13GOBSEVA SA COM
OBSVF
Medicxi Growth I LP1,570,000
2.850%
0
(Unchanged)
View
2021-02-11
08:41 am
Unchanged
13GMERUS N V COM
MRUS
Medicxi Growth I LP1,600,000
4.300%
0
(Unchanged)
View
2020-08-18
4:29 pm
Purchase
13GCheckmate Pharmaceuticals Inc.
CMPI
Medicxi Growth I LP1,501,716
7.000%
1,501,716increase
(New Position)
View
2020-02-10
12:00 pm
Purchase
13GPHATHOM PHARMACEUTICALS INC CO
PHAT
Medicxi Growth I LP2,067,861
8.400%
2,067,861increase
(New Position)
View